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1. Introduction 
Pure laparoscopic hepatectomy is thought to be a less invasive procedure than conventional 
open hepatectomy for the resection of hepatic lesions (1). Recent development of devices 
facilitates expansion of the indication of the procedure (2, 3). At the present moment, 
common advantages of laparoscopic surgery, such as early recovery and discharge with 
smaller postoperative pain and earlier intake, have been reported (4). However, specific 
advantages and/or disadvantages of pure laparoscopic hepatectomy for the settlement of 
the indication have yet to be sufficiently discussed.  
On the other hand, at the treatment of hepatocellular carcinoma (HCC) with liver cirrhosis, 
considerations for the control of invasive surgical stress, especially to impaired liver, should 
be placed besides oncological therapeutic effects. Patients with severe liver cirrhosis have 
various (overt and preliminary) symptoms, such as 1) deteriorations of protein synthesis 
and metabolism, 2) congestion of GI tract, ascites, pancytopenia due to portal hypertension 
and hypersplenism, 3) susceptibility to infectious diseases and hepatopulmonary syndrome 
(hypoxaemia) due to increased shunt vessels (5). Cirrhotic patients have high morbidity and 
mortality at undergoing anesthesia and surgery (6) and the risk of abdominal operations 
increases according to the preoperative Child’s class of the patients (7). Hepatic resection for 
severe cirrhotic patients, even minimum, often develops refractory ascites which leads to 
fatal complications (8, 9). In Japan, the criteria based on 3 parameters (the presence or 
absence of ascites, total serum billirubin level, and indocyanine green retension rate at 15 
minutes (ICG R15)) have been widely used for patient selection of hepatectomy (10). 
Nowadays, surgical resection, local ablation therapy or transarterial chemoembolization is 
adapted to each HCC patient with liver cirrhosis depending on the tumor condition and the 
liver function.  
However, not small number of HCC patients with severe liver dysfunction exists who is not 
able to undergo those treatment modalities due to liver function, tumor size and/or 
localization, especially after repeat treatments for the disease. Furthermore, not small 
portion of patients need the repeat treatments for multicentric metachronous lesions 
occurred in chronic impaired liver. For thosee patients, “less invasive” pure laparoscopic 
hepatectomy may provide a good option.  
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2. Pure laparoscopic hepatectomy for HCC patients with liver cirrhosis- our 
experiences 
From May 2005, 21 patients with hepatocellular carcinoma and chronic liver disease 
underwent pure laparoscopic hepatectomy. There were 6 out of 21 patients had severe liver 
cirrhosis (Child-Pugh B/C and ICG R15 of 40% or above) (Table 1). These 6 patients and the 
other 14 patients (Child A and ICG R15: 10.1- 27.4 (median: 13.4) %, excluded the patient 
with HCC and rectal carcinoma) were compared in operating time, intraoperative blood 
loss, day of oral ingestion started, day of drain removal, total dose of drain discharge from 
the operation day to post operative day 3, complication, and postoperative hospital stay.  
 
Age, Background Child-Pugh TB/DB PT Alb Tumor location, Postoperative 
Sex liver disease (ICGR15 (%)) (mg/dl) (%) (g/dl) Tumor size (mm) Complication 
64, M B,C B (42.8%) 1.3/0.3 79 3.2 S4 and 2-3, 44 Cholecyctitis 
53, M B B (41.2%) 1.5/0.4 75 3.4 S5-6, 28 no 
68, F C C (58.2%) 2.2/0.5 58 2.6 S8, 13 no 
40, M Alc B (52.5%) 1.7/0.4 74 2.8 S6-7, 20 no 
50, M C C (48.9%) 2.1/1.0 66 2.7 S5, 18 no 
75, F C B (42.5%) 1.3/0.8 63 3.2 S3, 30 no 
Table 1. Patients with severe liver cirrhosis who underwent pure laparoscopic hepatectomy 
B: type-B viral hepatitis, C: type-C viral hepatitis, Alc: alcoholic hepatitis 
For 6 patients with HCC and severe liver cirrhosis who underwent pure laparoscopic 
hepatectomy, the operating time was 140-341 (median: 232) minutes (for other patients with 
mild/moderate liver cirrhosis: 216-528 (295) minutes), the intraoperative blood loss was 
uncountable-213 (median: 58) ml  (for other patients with mild/moderate liver cirrhosis: 
uncountable -696 (43) ml), the day of oral ingestion started was postoperative day 1-3 (median: 
2)  (for other patients with mild/moderate liver cirrhosis: day 2-3 (2) ), the day of drain 
removal was postoperative day 3-6 (median: 4) (for other patients with mild/moderate liver 
cirrhosis: day 4-6 (5)), the total dose of drain discharge from the operation day to post 
operative day 3 was 279-1990 (median: 820) ml (for other patients with mild/moderate liver 
cirrhosis: 141-1275 (416) ml), and the postoperative hospital stay was 11-21 (median: 17) days 
(for other patients with mild/moderate liver cirrhosis: 9-254 (20) days). One patient developed 
postoperative complication of cholecystitis among 6 patients with severe liver cirrhosis, and 2 
patients developed postoperative complication of ileus and refractory ascites among other 14 
patients. There was no post-operative mortality in both groups. These results of perioperative 
course were comparable without statistically significant difference in the two groups. 
Perioperative course of HCC patients with severe liver cirrhosis who underwent pure 
laparoscopic hepatectomy was favorable and comparable to that of the other HCC patients 
with mild/moderate liver cirrhosis. (A case is shown in figures 1-5) 
Also, repeat pure laparoscopic hepatectomy (and combined treatments) for patients with 
liver cirrhosis and multicentric/metachronous HCCs was feasible and safe with advantage 
of less post-operative adhesion. (A case is shown in figures 6-10) 
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Fig. 1. A case with hepatocellular carcinoma and severe liver cirrhosis treated with pure 
laparoscopic hepatectomy 
50 years old man with type-C severe liver cirrhosis (Table 1, patient 5) developed 2 cm 
hepatocellular carcinoma (HCC) at the undersurface area of the segments 5, revealed in 
computed tomography (plain (A), arterial phase with contrast (B), venous phase (C)) and 
ultrasonography (D).  
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Fig. 2. Intraoperative findings of the case in figure 1 (1) 
The liver was highly atrophic with large shunt vessels in the round ligament and the hepatic 
flexure of the colon was migrating into the subphrenic space.  
 
 
Fig. 3. Intraoperative findings of the case in figure 1 (2) 
There were mild adhesions around the tumor. Dissection of the adhesion was performed, 
but not the mobilization of the liver. Since the liver was highly atrophic and the tumor was 
located deeply in the subphrenic space, mobilization of the liver was necessary for safe 
resection of the tumor under laparotomy. However, with laparoscopy, good direct vision 
and safe resection was obtained without mobilization.  
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Fig. 4. Intraoperative findings of the case in figure 1 (3) 
(A) After intraoperative ultrasonography, shallow cut in the surface area of the liver was 
made with harmonic scalpel.  
(B) In the deeper area of the liver, dissection was performed with CUSA, monopolar and 
bipolar electric cautery. Thicker vessels were clipped or ligated and divided.  
(C) The tissue with good coagulation with bipolar and monopolar was cut with scissors. 
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Fig. 5. Intraoperative findings (4) and resected specimen of the case in figure 1 
The operation time was 140 minutes and intraoperative blood loss was 100ml. His post-
operative hospital stay was uneventfull and 11 days. Pathologically, the tumor was 
moderately differentiated HCC in well differentiated HCC. He is alive without recurrence at 
16 months after surgery 
www.intechopen.com
 
Pure Laparoscopic Hepatectomy for HCC Patients 
 
189 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. A case with multicentric metachronous hepatocellular carcinomas and liver cirrhosis 
treated repeatedly with pure laparoscopic hepatectomy 
69 years old woman with type-C liver cirrhosis developed 2 cm HCC in the segments 3 and 
1.5cm in the border of segments 2 and 3, revealed in computed tomography (upper, arterial 
phase with contrast (A), venous phase (B)) and underwent pure laparoscopic hepatectomy 
(lower, arterial phase with contrast (C), venous phase (D)) in 2008. Pathological findings of 
the tumors were moderately (S3) and well (S2-3) differentiated hepatocellular carcinomas. 
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Fig. 7. A case with multicentric metachronous hepatocellular carcinomas and liver cirrhosis 
treated repeatedly with pure laparoscopic hepatectomy (2) 
In 2010, she developed 2.5 cm HCC at the undersurface area of the segments 6, revealed in 
computed tomography (plain (A), arterial phase with contrast (B), venous phase (C)) and 
ultrasonography. She also had two small hypovascular lesions in the borders of segments 3 
and 4, and of segments 4 and 8.  
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Fig. 8. Intraoperative findings of the case in figure 7 (1) 
Adhesions were observed at the resected area of the liver (A) and the port site (B). There 
was shunt vessel formation in the port site adhesion. Two small hypovascular lesions in the 
borders of segments 3 and 4, and of segments 4 and 8 were ablated with US-guided 
intraoperative MCT (C).  
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Fig. 9. Intraoperative findings of the case in figure 7 (2) 
There were also adhesions at the undersurface area of the right lobe of the liver after 
laparoscopic cholecystectomy performed 8 years ago (A). Dissection of the adhesion, but not 
the mobilization of the liver, exposed the tumor (B). After intraoperative ultrasonography, 
shallow cut in the surface area of the liver was made with harmonic scalpel (C). In the 
deeper area of the liver, dissection was performed with CUSA, monopolar and bipolar 
electric cautery. Thicker vessels were clipped or ligated and divided (D).   
C D
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Fig. 10. Intraoperative findings of the case in figure 7 (3) and resected specimen of the case 
in figure  
The operation time was 168 minutes and intraoperative blood loss was 30ml. Her post-
operative hospital stay was uneventfull 9 days. Pathologically, the tumor was moderately 
differentiated HCC. She is alive without recurrence at 6 months after surgery 
3. Discussion 
Mirnezami et al recently reported systematic review and meta-analysis for short- and 
long-term outcomes after laparoscopic and open hepatic resection, with twenty-six studies 
met the inclusion criteria with a population of 1678 patients (60% of the patients had 
malignant liver tumor) (11). In their study, laparoscopic hepatectomy resulted in longer 
operating time, but reduced blood loss, portal clamp time, overall and liver-specific 
complications, and length of post-operative hospital stay. No difference was found 
between two groups for oncological outcomes. The benefits of laparoscopy may be 
particularly great for cirrhotic patients, given the potential for lower levels of parietal and 
hepatic injury and the preservation of venous and lymphatic collateral circulation. The 
safety and feasibility of the laparoscopic approach and its short-term benefits for HCC 
have been demonstrated by a few series to date (12-19). Tranchart et al recently reported 
laparoscopic resection of HCC for selected patients gave a better postoperative outcome 
without long- and short-term oncologic consequences from their series (42 each 
laparoscopic- and open-hepatectomy patients, with more than 96% Child A patients and 
mostly anatomical resection) (20). In our experience, perioperative course of 6 HCC 
patients with severe liver cirrhosis (Child B/C and ICG R15 of 40% or above) who 
underwent pure laparoscopic hepatectomy was favorable and comparable to that of the 
other HCC patients with mild/moderate liver cirrhosis.  
Early postoperative recovery and discharge with smaller postoperative pain and earlier 
intake are advantages in pure laparoscopic hepatectomy for severe cirrhotic patients as the 
other laparoscopic surgery. On top of that, we consider that relatively small amount 
(median 230 ml/day) of drain discharge of severe liver cirrhosis patients, some (case 3, 5, 6 
in table 1) of whom had mild or controllable ascites before surgery, was the other benefit of 
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pure laparoscopic hepatectomy for these patients in our series. Pure laparoscopic 
hepatectomy might have possible advantage of minimal postoperative drain discharge 
(ascites) which leads to lower risk of disturbance in water/electrolyte balance and 
hypoproteinemia. These disorders could trigger fatal liver failure. There are also reports 
which described little development of postoperative ascites on laparoscopic hepatectomy 
(14, 17). In case of pure laparoscopic hepatectomy for severe cirrhotic patients, this feature 
could be the most remarkable specific advantage for postoperative course. Patients who 
undergo hepatectomy are exposed three different types of stresses, 1) general surgical stress 
for whole body depends on operating time, amount of bleeding etc, 2) reduced liver 
function due to resected liver volume, 3) injury for liver parenchyma and environment 
around the liver by surgical procedure (destruction of the collateral blood and lymphatic 
flow caused by laparotomy and mobilization of the liver and, also, mesenchymal injury 
caused by compression of the liver). We consider that the reduction of the third type of 
stress mentioned above with pure laparoscopic hepatectomy leads to lowering the risk of 
refractory ascites, resulting in reduced risk of successive complications and smooth recovery 
for HCC patients with severe liver cirrhosis.  
Liver surface HCC with severe liver cirrhosis is not the good candidate of percutaneous 
ablation therapy due to the concern about hemorrhage, tumor dissemination, and injury of 
adjacent organs. There are reports of microwave or radiofrequency ablation therapy under 
mini-laparotomy or laparoscopy for those tumors as safe and less invasive procedure (21). 
However, surgery should obtain better control for the tumor located in the surface area with 
minimum reduction of liver function, as Buell et al described (22). We think pure 
laparoscopic hepatectomy for those tumors with minimum invasiveness could be 
established as a feasible and more effective treatment modality. The tumor located deep in 
the liver with severe cirrhosis should be good candidate of percutaneous ablation therapy. 
The resection of the tumor located in the surface but bare area of the liver should need 
dissection of the attachments and mobilization of the liver. For these tumors, transpleural or 
retroperitoneal approach may need to be considered for reducing invasiveness. For the 
extension of the indication, hand-assisted laparoscopic hepatectomy with the incision for 
hand port in the lower abdomen (2), robotic hepatectomy (23), and single-incision 
laparoscopic hepatectomy (24) might be a good option as conventional pure laparoscopic 
hepatectomy, although further investigation is needed.   
In conclusion, our experiences suggest that pure laparoscopic hepatectomy for HCC patients 
with severe liver cirrhosis has specific advantage of minimal postoperative ascite production 
which leads to lower risk of disturbance in water/electrolyte balance and hypoproteinemia. 
The procedure minimize destruction of the collateral blood and lymphatic flow caused by 
laparotomy and mobilization of the liver and, also, mesenchymal injury caused by 
compression of the liver. It restrains the complications, which lead to the postoperative 
serious liver failure, such as massive ascites. Severe cirrhotic patients with tumors on the 
surface of the liver, in case of difficult adaptation of percutaneous ablation therapy and/or 
local recurrence after repeat treatments, are the good candidates for this procesure. 
Furthermore, repeat pure laparoscopic hepatectomy (and combined treatments) for patients 
with liver cirrhosis and multicentric/metachronous HCCs was feasible and safe with 
advantage of less post-operative adhesion and the procedure could be good option of 
bridging therapy to liver transplantation for the patients with severe liver cirrhosis and 
small HCC. 
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